Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Construction in Progress (2018 - 2019)

Historic Construction in Progress for Autolus Therapeutics (AUTL) over the last 2 years, with Q1 2019 value amounting to $2.0 million.

  • Autolus Therapeutics' Construction in Progress changed N/A to $2.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Autolus Therapeutics reported Construction in Progress of $2.0 million as of Q1 2019.
  • In the past 5 years, Autolus Therapeutics' Construction in Progress registered a high of $8.6 million during Q4 2018, and its lowest value of $2.0 million during Q1 2019.